deoxyepinephrine has been researched along with Exfoliation Syndrome in 1 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Exfoliation Syndrome: The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. It sometimes forms a membrane on the anterior iris surface. Exfoliation refers to the shedding of pigment by the iris. (Newell, Ophthalmology, 7th ed, p380)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taverniti, L | 1 |
| Di Staso, S | 1 |
| Arrico, L | 1 |
| D'Ubaldo, E | 1 |
| Grenga, R | 1 |
1 other study available for deoxyepinephrine and Exfoliation Syndrome
| Article | Year |
|---|---|
The ibopamine test in patients affected by monolateral pseudoexfoliative glaucoma.
Topics: Aqueous Humor; Deoxyepinephrine; Dopamine Agonists; Exfoliation Syndrome; Glaucoma; Humans; Intraocu | 2000 |